Prognostic Value of Coronary Sinus Flow Quantification by Cardiac Magnetic Resonance Imaging in Patients With Acute Myocardial Infarction.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
03 2022
Historique:
pubmed: 19 2 2022
medline: 9 4 2022
entrez: 18 2 2022
Statut: ppublish

Résumé

Background This study aimed to evaluate the prognostic value of hyperemic coronary sinus flow (h-CSF) and global coronary flow reserve (g-CFR) obtained by phase-contrast cine-magnetic resonance imaging in patients with acute myocardial infarction (MI). Methods and Results This retrospective study analyzed patients with acute MI (n=523) who underwent primary (ST-segment-elevation MI) or urgent (non-ST-segment-elevation MI) percutaneous coronary intervention. Absolute coronary sinus blood flow (CSF) at rest and during vasodilator stress hyperemia was quantified at 30 days (24-36 days) after the index infarct-related lesion percutaneous coronary intervention and revascularization of functionally significant non-infarct-related lesions. We used Cox proportional hazards regression modeling to examine the association between h-CSF, g-CFR, and major adverse cardiac events defined as all-cause death, nonfatal MI, hospitalization for congestive heart failure, and stroke. Finally, 325 patients with ST-segment-elevation MI (62.1%) and 198 patients with non-ST-segment-elevation MI (37.9%) were studied over a median follow-up of 2.5 years. The rest CSF, h-CSF, and g-CFR were 0.94 (0.68-1.26) mL/min per g, 2.05 (1.42-2.73) mL/min per g, and 2.17 (1.54-3.03), respectively. Major adverse cardiac events occurred in 62 patients, and Cox proportional hazards analysis showed that h-CSF and g-CFR were independent predictors of major adverse cardiac events (h-CSF: hazard ratio [HR], 0.64; 95% CI, 0.47-0.88;

Identifiants

pubmed: 35179042
doi: 10.1161/JAHA.121.023519
pmc: PMC9075062
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e023519

Références

J Am Coll Cardiol. 2009 Jul 7;54(2):150-6
pubmed: 19573732
JACC Cardiovasc Imaging. 2019 Aug;12(8 Pt 2):1686-1695
pubmed: 30409558
Circulation. 2017 Feb 7;135(6):566-577
pubmed: 27881570
Eur Heart J. 2018 Mar 7;39(10):840-849
pubmed: 29293969
J Magn Reson Imaging. 2001 Mar;13(3):361-6
pubmed: 11241807
JAMA. 2012 Sep 12;308(10):998-1006
pubmed: 22928184
Int J Cardiovasc Imaging. 2017 Jul;33(7):1041-1059
pubmed: 28501910
N Engl J Med. 2007 Feb 22;356(8):830-40
pubmed: 17314342
Am J Med. 2019 Jun;132(6):692-697
pubmed: 30684452
Circulation. 2016 Mar 15;133(11):1135-47
pubmed: 26490017
Circulation. 2015 Jan 6;131(1):19-27
pubmed: 25400060
Circulation. 2017 Dec 12;136(24):2325-2336
pubmed: 28864442
Circulation. 2001 Nov 13;104(20):2401-6
pubmed: 11705815
Eur Heart J Cardiovasc Imaging. 2020 Jul 1;21(7):777-786
pubmed: 31620792
JACC Cardiovasc Interv. 2012 Sep;5(9):893-902
pubmed: 22995875
Circulation. 2020 Apr 21;141(16):1282-1291
pubmed: 32078380
JACC Cardiovasc Imaging. 2019 Oct;12(10):1958-1969
pubmed: 30772231
Circulation. 2011 Nov 15;124(20):2215-24
pubmed: 22007073
Heart. 2012 May;98(9):699-705
pubmed: 22523054
JACC Cardiovasc Imaging. 2012 Apr;5(4):430-40
pubmed: 22498334
Circulation. 2000 Jun 13;101(23):2696-702
pubmed: 10851206
J Am Coll Cardiol. 2019 Feb 19;73(6):684-693
pubmed: 30765035
AJR Am J Roentgenol. 2001 Nov;177(5):1161-6
pubmed: 11641194
J Am Coll Cardiol. 2017 Aug 15;70(7):869-879
pubmed: 28797357

Auteurs

Yoshihisa Kanaji (Y)

Division of Cardiovascular Medicine Tsuchiura Kyodo General Hospital Ibaraki Japan.

Tomoyo Sugiyama (T)

Division of Cardiovascular Medicine Tsuchiura Kyodo General Hospital Ibaraki Japan.

Masahiro Hoshino (M)

Division of Cardiovascular Medicine Tsuchiura Kyodo General Hospital Ibaraki Japan.

Yumi Yasui (Y)

Division of Cardiovascular Medicine Tsuchiura Kyodo General Hospital Ibaraki Japan.

Kai Nogami (K)

Division of Cardiovascular Medicine Tsuchiura Kyodo General Hospital Ibaraki Japan.

Hiroki Ueno (H)

Division of Cardiovascular Medicine Tsuchiura Kyodo General Hospital Ibaraki Japan.

Teng Yun (T)

Division of Cardiovascular Medicine Tsuchiura Kyodo General Hospital Ibaraki Japan.

Tatsuhiro Nagamine (T)

Division of Cardiovascular Medicine Tsuchiura Kyodo General Hospital Ibaraki Japan.

Toru Misawa (T)

Division of Cardiovascular Medicine Tsuchiura Kyodo General Hospital Ibaraki Japan.

Masahiro Hada (M)

Division of Cardiovascular Medicine Tsuchiura Kyodo General Hospital Ibaraki Japan.

Masao Yamaguchi (M)

Division of Cardiovascular Medicine Tsuchiura Kyodo General Hospital Ibaraki Japan.

Rikuta Hamaya (R)

Division of Cardiovascular Medicine Tsuchiura Kyodo General Hospital Ibaraki Japan.

Eisuke Usui (E)

Division of Cardiovascular Medicine Tsuchiura Kyodo General Hospital Ibaraki Japan.

Tadashi Murai (T)

Division of Cardiovascular Medicine Tsuchiura Kyodo General Hospital Ibaraki Japan.

Taishi Yonetsu (T)

Department of Cardiovascular Medicine Tokyo Medical and Dental University Tokyo Japan.

Tetsuo Sasano (T)

Department of Cardiovascular Medicine Tokyo Medical and Dental University Tokyo Japan.

Tsunekazu Kakuta (T)

Department of Cardiovascular Medicine Tokyo Medical and Dental University Tokyo Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH